Ardelyx (ARDX) Non-Current Deferred Revenue (2013 - 2026)
Ardelyx's Non-Current Deferred Revenue was $13.7 million in Q3 2026, unchanged from $13.7 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ardelyx (ARDX) Non-Current Deferred Revenue (2013 - 2026) Analysis & Trends
From Q4 2013 onward, Ardelyx has reported Non-Current Deferred Revenue for 28 quarters.
- Non-Current Deferred Revenue shows a four-year compound annual growth rate of 30.5% (FY2021 to FY2025).
- In earlier years, Non-Current Deferred Revenue was $7.23 million in FY2024 (-16.3%), $8.64 million in FY2023 (-4.2%), $9.03 million in FY2022 (+90.9%) and $4.73 million in FY2021.
- Compared with a year earlier, Non-Current Deferred Revenue was higher in five of the last eight quarters, with growth averaging 19.1%.
- The best year-over-year quarter for Non-Current Deferred Revenue over five years was Q2 2022 (growth of 321.5%); the worst was Q1 2025 (a decline of 31.0%).
- Per Business Quant data, ARDX's Non-Current Deferred Revenue in the three quarters before Q3 2026 was $13.7 million (Q2 2026), $13.7 million (Q1 2026) and $13.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Ardelyx | 755.60 Mn | -314.33 Mn | 123.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.70 Mn |
| Jun 30, 2026 | 13.70 Mn |
| Mar 31, 2026 | 13.70 Mn |
| Dec 31, 2025 | 13.70 Mn |
| Sep 30, 2025 | 13.70 Mn |
| Jun 30, 2025 | 12.30 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 12.77 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Dec 31, 2023 | 8.64 Mn |
| Sep 30, 2023 | 10.29 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 11.50 Mn |
| Dec 31, 2022 | 9.03 Mn |
| Sep 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 12.42 Mn |
| Mar 31, 2022 | 8.56 Mn |
| Dec 31, 2021 | 4.73 Mn |
API Access
Ardelyx Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();